Found: 24
Select item for more details and to access through your institution.
Cancer and COVID-19: US cancer incidence rates during the first year of the pandemic.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 208, doi. 10.1093/jnci/djad205
- By:
- Publication type:
- Article
Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 189, doi. 10.1093/jnci/djad227
- By:
- Publication type:
- Article
Black cancer patients navigating a health-care system of racial discrimination.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 258, doi. 10.1093/jnci/djad208
- By:
- Publication type:
- Article
Taxanes for the treatment of breast cancer during pregnancy: an international cohort study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 239, doi. 10.1093/jnci/djad219
- By:
- Publication type:
- Article
RE: Autoimmune disease and the risk of anal cancer in the US elderly population.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 338, doi. 10.1093/jnci/djad204
- By:
- Publication type:
- Article
Improving our treatment of breast cancer during pregnancy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 183, doi. 10.1093/jnci/djad259
- By:
- Publication type:
- Article
Much work to do about measuring work.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 194, doi. 10.1093/jnci/djad258
- By:
- Publication type:
- Article
The most frequent forms of premature death from cancer in 185 countries in 2022 (both sexes combined).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 340, doi. 10.1093/jnci/djad249
- Publication type:
- Article
Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 200, doi. 10.1093/jnci/djad239
- By:
- Publication type:
- Article
Special designations and the US Food and Drug Administration's "dual mandate".
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 177, doi. 10.1093/jnci/djad235
- By:
- Publication type:
- Article
Human papillomavirus–associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates—United States, 2001-2019.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 275, doi. 10.1093/jnci/djad214
- By:
- Publication type:
- Article
Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 249, doi. 10.1093/jnci/djad201
- By:
- Publication type:
- Article
Are linchpin oncologists keeping the wheels from falling off cancer care?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 180, doi. 10.1093/jnci/djad216
- By:
- Publication type:
- Article
Disparities in outcomes and access to therapy options in hepatocellular carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 264, doi. 10.1093/jnci/djad213
- By:
- Publication type:
- Article
Clinical benefit, development, innovation, trials, epidemiology, and price for cancer drugs and indications with multiple special FDA designations.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 216, doi. 10.1093/jnci/djad212
- By:
- Publication type:
- Article
Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 334, doi. 10.1093/jnci/djad203
- By:
- Publication type:
- Article
Processes for identifying caregivers and screening for caregiver and patient distress in community oncology: results from WF-1803CD.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 324, doi. 10.1093/jnci/djad198
- By:
- Publication type:
- Article
Trends in new and persistent opioid use in older adults with and without cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 316, doi. 10.1093/jnci/djad206
- By:
- Publication type:
- Article
Human papillomavirus vaccination and anal high-grade precancerous lesions and cancer—a real-world effectiveness study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 283, doi. 10.1093/jnci/djad189
- By:
- Publication type:
- Article
Conjunctival squamous cell carcinoma in people with HIV in South Africa: time to renew efforts for novel oncogenic virus discovery?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 186, doi. 10.1093/jnci/djad147
- By:
- Publication type:
- Article
Autoimmune disease and the risk of anal cancer in the US population aged 66 years and over.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 309, doi. 10.1093/jnci/djad187
- By:
- Publication type:
- Article
Association between a network-based physician linchpin score and cancer patient mortality: a SEER-Medicare analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 230, doi. 10.1093/jnci/djad180
- By:
- Publication type:
- Article
Evolving therapies, neurocognitive outcomes, and functional independence in adult survivors of childhood glioma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 288, doi. 10.1093/jnci/djad190
- By:
- Publication type:
- Article
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 2, p. 299, doi. 10.1093/jnci/djad186
- By:
- Publication type:
- Article